Article Sidebar

PDF
Date Published: 20/07/2021
Abstract Views: 143
Views PDF: 147
DOI: https://doi.org/10.51298/vmj.v501i1.426
Issue
Vol. 501 No. 1 (2021)
Section
Các bài báo
How to Cite
Tấn, Đỗ ., Thị Thu Thủy, P. ., & Đức Thịnh, N. . (2021). EVALUATING THE EFFICACY OF SLT ON OAG PATIENTS TREATED WITH IOP LOWERING MEDICATIONS. Vietnam Medical Journal, 501(1). https://doi.org/10.51298/vmj.v501i1.426

EVALUATING THE EFFICACY OF SLT ON OAG PATIENTS TREATED WITH IOP LOWERING MEDICATIONS

Đỗ Tấn, Phạm Thị Thu Thủy, Nguyễn Đức Thịnh

Main Article Content

Abstract

Objectives: to evaluate the efficacy of SLT on OAG patients who has been treated medically. Patients and methods: Descriptive study on 40 eyes of 28 POAG and steroid-induced patients on IOP lowering medications who have been treated with 360o SLT. VA, VF, IOP, gonioscopy, optic disc, Laser settings, number of IOP lowering medications were evaluated before treatment and after treatment at 2 weeks, 1 month, 3 months. Results: mean age was 48,95 ± 15,76 year old, male/female ratio was comparable (55% và 45%); mean duration of disease was 21,33 ± 31,2 months; majority of patients were at advanced or severe stages. Mean IOP before laser was 27,48 ± 5,92 mmHg, which was lowered to 20,05 ± 4,36 mmHg at 2 weeks; 17,98 ± 5,73 mmHg at 1 month; 16,36 ± 3,58 mmHg at 3 months with equivalent percentage of 26%; 31%, 39% respectively. Number of IOP lowering agents before treatment were 3,05 ± 0.75, reduced to 2,15 ± 1,1 medications at 1 month and 1,76 ± 0,97 medications at 3 months. Eyes at early and severe stage had highest IOP lowering percentage at 3 months (37 – 42%), while eyes at advanced stage had highest IOP lowering at 1 month (38%). VA, VF and angle remained unchanged after laser. Complications of laser including eye irritation (7.5%), mild conjunctival hyperemia (10%) were usually transient. Conclusion: SLT was safe and effective in treating OAG patients already on IOP lowering medications.

Article Details

Keywords

SLT, OAG, IOP lowering medications

References

1. Shingleton BJ, Richter CU, Dharma SK, et al. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmology. 1993;100(9):1324-1329.
2. Anderson RR, Parish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983 Apr; 220(4596):524-527.
3. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol. 2003;121(7):957-960. doi:10.1001/ archopht.121.7.957
4. Mahdy MA-MS. Efficacy and Safety of Selective Laser Trabeculoplasty as a Primary Procedure for Controlling Intraocular Pressure in Primary Open Angle Glaucoma and Ocular Hypertensive Patients. Sultan Qaboos Univ Med J. 2008;8(1):53-58.
5. Johnson C, Li J, Kirk C. Long Term Effect and Predictive Factors of Success for Selective Laser Trabeculoplasty (SLT). Invest Ophthalmol Vis Sci. 2018;59(9):6088-6088.
6. Xu L, Yu R-J, Ding X-M, et al. Efficacy of low-energy selective laser trabeculoplasty on the treatment of primary open angle glaucoma. Int J Ophthalmol. 2019;12(9):1432-1437. doi:10.18240/ijo.2019.09.10
7. Nagar M, Ogunyomade A, O’Brart DPS, Howes F, Marshall J. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol. 2005;89(11):1413-1417. doi:10.1136/bjo.2004.052795
8. Cheema SA, McGlynn RH, George MK, et al. Efficacy of 180 vs. 360 Degrees of Selective Laser Trabeculoplasty on Lowering Intraocular Pressure. Invest Ophthalmol Vis Sci. 2006;47(13):5466-5466.
9. Shibata M, Sugiyama T, Ishida O, et al. Clinical results of selective laser trabeculoplasty in open-angle glaucoma in Japanese eyes: comparison of 180 degree with 360 degree SLT. J Glaucoma. 2012;21(1):17-21. doi:10.1097/ IJG.0b013e3181fc8020